Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
31.17
+1.38 (4.65%)
At close: May 29, 2026, 4:00 PM EDT
31.16
0.00 (-0.02%)
After-hours: May 29, 2026, 5:41 PM EDT
Tectonic Therapeutic Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
60
Market Cap
588.06M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rigel Pharmaceuticals | 299.77M |
| Valneva SE | 180.25M |
| Ginkgo Bioworks Holdings | 151.40M |
| Arvinas | 89.40M |
| ProKidney | 889.00K |
| Altimmune | 36.00K |
TECX News
- 5 days ago - Tectonic Therapeutic upgraded to Strong Buy from Outperform at Raymond James - TheFly
- 24 days ago - Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 24 days ago - Tectonic Therapeutic Quarterly report: Q1 2026 - Filings
- 24 days ago - Tectonic Therapeutic Earnings release: Q1 2026 - Filings
- 24 days ago - Tectonic Therapeutic Slides: Investor presentation - Filings
- 4 weeks ago - Tectonic Therapeutic management to meet with Piper Sandler - TheFly
- 5 weeks ago - Tectonic Therapeutic Proxy statement: Proxy filing - Filings
- 5 weeks ago - Tectonic Therapeutic Proxy statement: Proxy filing - Filings